Is MHTZF or MRK a better dividend investment in 2026?

MHTZF currently yields 11363.64% with a 5% 5-year dividend growth rate. MRK yields 2.76% with 8.2% growth. The better choice depends on your goal: MHTZF offers higher current income.

What is the dividend yield difference between MHTZF and MRK?

MHTZF has a forward dividend yield of 11363.64% ($2.00/share annually). MRK yields 2.76% ($3.32/share annually). The yield gap is 11360.88 percentage points.

Home › Compare › MHTZF vs MRK

MHTZF vs MRK: Dividend Comparison 2026

MHTZF yields 11363.64% · MRK yields 2.76%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 MHTZF wins by $194547359714770368.00M in total portfolio value

INVESTMENT

TIME HORIZON10 years

MHTZF

● Live price

11363.64%

Share price

$0.02

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$194547359714770368.00M

Annual income

$191,236,871,251,326,840,000,000.00

Full MHTZF calculator →

MRK

Merck & Co. Inc.

● Live price

2.76%

Share price

$120.31

Annual div

$3.32

5Y div CAGR

32.7%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$56.8K

Annual income

$9,798.13

Full MRK calculator →

Portfolio growth — MHTZF vs MRK

📍 MHTZF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	MHTZF	MRK
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, MHTZF + MRK cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

MHTZF pays

MRK pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

MHTZF

Annual income on $10K today (after 15% tax)

$965,909.09/yr

After 10yr DRIP, annual income (after tax)

$162,551,340,563,627,800,000,000.00/yr

MRK

Annual income on $10K today (after 15% tax)

$234.56/yr

After 10yr DRIP, annual income (after tax)

$8,328.41/yr

At 15% tax rate, MHTZF beats the other by $162,551,340,563,627,800,000,000.00/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of MHTZF + MRK for your $10,000?

MHTZF: 50%MRK: 50%

100% MRK50/50100% MHTZF

Portfolio after 10yr

$97273679857385184.00M

Annual income

$95,618,435,625,663,420,000,000.00/yr

Blended yield

98.30%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

MHTZF

No analyst data

Altman Z

927.9

Piotroski

3/9

MRK

Analyst Ratings

Buy

Hold

Sell

Consensus: Buy

Price Target

$128.54

+6.8% upside vs current

Range: $100.00 — $150.00

Altman Z

4.0

Piotroski

6/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

MHTZF buys

MRK buys

No recent congressional trades found for MHTZF or MRK in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricMHTZFMRK

Forward yield	11363.64% ✓	2.76%
Annual dividend / share	$2.00	$3.32 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	32.7% ✓
Portfolio after 10y	$194547359714770368.00M ✓	$56.8K
Annual income after 10y	$191,236,871,251,326,840,000,000.00 ✓	$9,798.13
Total dividends collected	$194327517780892000.00M ✓	$28.9K
Payment frequency	quarterly	quarterly
Sector	Stock	Healthcare

Year-by-year: MHTZF vs MRK ($10,000, DRIP)

Year	MHTZF Portfolio	MHTZF Income/yr	MRK Portfolio	MRK Income/yr	Gap
1← crossover	$1,147,064	$1,136,363.64	$11,206	$366.19	+$1.14M → MHTZF
2	$123,048,050	$121,820,692.05	$12,650	$502.35	+$123.04M → MHTZF
3	$12,344,721,917	$12,213,060,503.81	$14,407	$694.19	+$12344.71M → MHTZF
4	$1,158,319,112,910	$1,145,110,260,458.09	$16,585	$967.82	+$1158319.10M → MHTZF
5	$101,657,140,685,132	$100,417,739,234,318.14	$19,342	$1,363.89	+$101657140.67M → MHTZF
6	$8,345,152,271,706,471	$8,236,379,131,173,380.00	$22,913	$1,947.19	+$8345152271.68M → MHTZF
7	$640,830,145,068,942,800	$631,900,832,138,217,000.00	$27,662	$2,823.89	+$640830145068.92M → MHTZF
8	$46,035,325,463,581,610,000	$45,349,637,208,357,850,000.00	$34,159	$4,173.35	+$46035325463581.58M → MHTZF
9	$3,093,914,451,816,400,000,000	$3,044,656,653,570,367,600,000.00	$43,337	$6,308.80	+$3093914451816400.00M → MHTZF
10	$194,547,359,714,770,370,000,000	$191,236,871,251,326,840,000,000.00	$56,776	$9,798.13	+$194547359714770368.00M → MHTZF

MHTZF vs MRK: Complete Analysis 2026

MHTZF — Stock

Manhattan Corporation Limited engages in the evaluation, exploration, and development of mineral projects in Australia. The company explores for uranium and gold. Its flagship project is the 100% owned Tibooburra Gold project comprising 15 granted exploration licenses covering an area of approximately 2,200 square kilometers located in the Koonenberry Gold District, New South Wales. The company is based in West Perth, Australia.

Full MHTZF Calculator →

MRK — Healthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →

📬

Get this MHTZF vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

MHTZF vs SCHD MHTZF vs JEPI MHTZF vs O MHTZF vs KO MHTZF vs MAIN MHTZF vs JNJ MHTZF vs ABBV MHTZF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.